Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Friesen

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Journal of Medicinal Chemistry|May 30, 2003
Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinityRichard W Friesen, Yves Ducharme, Richard G Ball, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseasesMichel Gallant, Christian Beaulieu, Carl Berthelette, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Journal of Medicinal Chemistry|May 30, 2003
Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinityRichard W Friesen, Yves Ducharme, Richard G Ball, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseasesMichel Gallant, Christian Beaulieu, Carl Berthelette, et al.
Pageof 6